647 related articles for article (PubMed ID: 17951135)
1. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus.
Fukumoto T; Shiroyama Y; Niizeki H; Kobayashi N; Asada H; Ishii N; Hashimoto T; Miyagawa S
J Dermatol; 2007 Sep; 34(9):645-9. PubMed ID: 17727368
[TBL] [Abstract][Full Text] [Related]
3. Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia?
Laffitte E; Panizzon RG; Borradori L
Dermatology; 2008; 217(4):337-9. PubMed ID: 18799879
[TBL] [Abstract][Full Text] [Related]
4. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
5. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
[TBL] [Abstract][Full Text] [Related]
6. Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
Nakashima H; Fujimoto M; Watanabe R; Ishiura N; Yamamoto AI; Hashimoto T; Tamaki K
J Dermatol; 2010 Mar; 37(3):264-8. PubMed ID: 20507392
[TBL] [Abstract][Full Text] [Related]
7. Recalcitrant facial pemphigus vulgaris: correlation of skin lesions with the ratio of antidesmoglein antibodies 1 and 3.
Fujii M; Honma M; Iinuma S; Kaneta K; Komatsu S; Sato K; Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2011 Apr; 36(3):284-7. PubMed ID: 21418270
[TBL] [Abstract][Full Text] [Related]
8. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
9. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
Huang Y; Li J; Zhu X
Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
[TBL] [Abstract][Full Text] [Related]
11. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
Mimouni D; Foedinger D; Kouba DJ; Orlow SJ; Rappersberger K; Sciubba JJ; Nikolskaia OV; Cohen BA; Anhalt GJ; Nousari CH
J Am Acad Dermatol; 2004 Jul; 51(1):62-7. PubMed ID: 15243525
[TBL] [Abstract][Full Text] [Related]
12. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
Ishii K; Amagai M
Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
[TBL] [Abstract][Full Text] [Related]
13. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?
Torzecka JD; Woźniak K; Kowalewski C; Waszczykowska E; Sysa-Jedrzejowska A; Pas HH; Narbutt J
Arch Dermatol Res; 2007 Aug; 299(5-6):239-43. PubMed ID: 17534636
[TBL] [Abstract][Full Text] [Related]
14. [Desmoglein 1-negative, desmoglein 3-positive pemphigus herpetiformis with involvement of oral mucous membranes].
Brod C; Fierlbeck G; Metzler G; Sönnichsen K; Röcken M; Schaller M
J Dtsch Dermatol Ges; 2005 Apr; 3(4):280-2. PubMed ID: 16370478
[TBL] [Abstract][Full Text] [Related]
15. IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.
Kopp T; Sitaru C; Pieczkowski F; Schneeberger A; Födinger D; Zillikens D; Stingl G; Karlhofer FM
J Dtsch Dermatol Ges; 2006 Dec; 4(12):1045-50. PubMed ID: 17176412
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3.
Bouloc A; Joly P; Saint-Leger E; Wechsler J; Roujeau JC; Revuz J
J Am Acad Dermatol; 2000 Oct; 43(4):714-7. PubMed ID: 11004638
[TBL] [Abstract][Full Text] [Related]
18. IgG/IgA pemphigus with dyskeratotic acantholysis and intraepidermal neutrophilic microabscesses.
Nakajima K; Hashimoto T; Nakajima H; Yokogawa M; Ikeda M; Kodama H
J Dermatol; 2007 Nov; 34(11):757-60. PubMed ID: 17973815
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of rituximab in patients with severe pemphigus.
Schmidt E; Hennig K; Mengede C; Zillikens D; Kromminga A
Clin Immunol; 2009 Sep; 132(3):334-41. PubMed ID: 19502112
[TBL] [Abstract][Full Text] [Related]
20. Atypical pemphigus involving the esophagus with IgG antibodies to desmoglein 3 and IgA antibodies to desmoglein 1.
Inui S; Amagai M; Tsutsui S; Fukuhara-Yoshida S; Itami S; Katayama I
J Am Acad Dermatol; 2006 Aug; 55(2):354-5. PubMed ID: 16844530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
